Hepatocyte growth factor (HGF) is involved in malignant behavior of cancer cells by enhancing invasion and metastasis. We earlier found that NK4, a four-kringle fragment of HGF, functions as both an HGF antagonist and an angiogenesis inhibitor. We have now carried out studies to determine if hydrodynamics-based delivery and expression of the NK4 gene would inhibit liver metastasis and invasive growth of colon carcinoma cells in mice. When the naked plasmid for NK4 was introduced into mice by hydrodynamicsbased gene delivery, a high level of expression of NK4 was predominant in the liver. After intrasplenic inoculation of MC-38 murine colon carcinoma cells, the cells formed numerous metastatic nodules in the liver and showed invasive growth behavior. On the other hand, when mice were given the NK4 plasmid, hepatic gene expression of NK4 inhibited the liver metastasis and subsequent growth associated with a decrease in microvessel density. Likewise, intrahepatic invasion of cancer cells was inhibited by NK4 gene expression, and this anti-invasive effect was associated with in situ inhibition of c-Met receptor tyrosine phosphorylation. Moreover, NK4 gene expression prolonged survival of these mice. Taken together with the knowledge that the majority of deaths from colon cancer are due to liver metastasis, the potential therapeutic use of hepatic gene expression of NK4 for metastatic colon cancer treatment can be given consideration. Cancer Gene Therapy ( Keywords: c-Met; colon cancer; HGF; liver metastasis; NK4; tumor angiogenesis C olon carcinoma represents one of the most frequently occurring cancers and is associated with a high mortality. The majority of deaths with colon cancer are secondary to metastatic disease, with the liver being overwhelmingly the most frequent site of metastases. 1 Even though surgical resection, which can be effective for liver metastasis, the 5-year survival rate is only 20-40%.
C olon carcinoma represents one of the most frequently occurring cancers and is associated with a high mortality. The majority of deaths with colon cancer are secondary to metastatic disease, with the liver being overwhelmingly the most frequent site of metastases. 1 Even though surgical resection, which can be effective for liver metastasis, the 5-year survival rate is only 20-40%. 2 Multimodal chemotherapy, the mainstay of treatment for patients with metastatic cancer, may prolong survival but this approach can also decrease the quality of life. 3 Hence, there is a need to develop novel strategies for the treatment of colon carcinoma, wherein inhibition of liver metastasis and subsequent invasive growth of liver metastases may prove to be a new therapeutic approach.
Hepatocyte growth factor (HGF), originally identified and cloned as a mitogenic protein for hepatocytes, 4, 5 potently enhances dissociation of cell-cell adhesiveness, cell motility, and extracellular matrix breakdown in a variety of cancer cells, thereby leading to the invasion and metastasis of cancer cells. [6] [7] [8] Previous studies indicated that the HGF-Met receptor system is involved in the malignant behavior of colon carcinoma cells. HGF enhances migration and expression of matrix metalloproteases, thereby facilitating the invasion of colon cancer cells. [9] [10] [11] [12] In colorectal cancers, overexpression of the Met receptor was seen to be related to transcriptional activation in 90% of the primary tumors, whereas eight of nine cases of metastases from colorectal cancers showed amplification of the met gene. 13 Therefore, inhibition of the HGF-Met receptor system is an important approach to inhibit metastasis of tumors, including colon carcinoma.
We earlier prepared NK4 as a competitive antagonist for HGF-Met association. 8, 14 NK4 is composed of the NH 2 -terminal hairpin domain and four-kringle domains in the a-chain of HGF. NK4 binds to the c-Met receptor and competitively antagonizes HGF-induced tyrosine phosphorylation of the c-Met receptor, the result being inhibition of HGF-mediated invasion of distinct types of cancer cells, including colon cancer cells. 8, 15, 16 We recently found that NK4 is also an angiogenesis inhibitor and has inhibitory effects on angiogenesis driven by basic fibroblast growth factor and vascular endothelial growth factor, as well as HGF. 17 As angiogenesis in malignant tumors is involved in tumor growth and metastasis, 18, 19 bifunctional properties of NK4, an HGF antagonist and an angiogenesis inhibitor, raised the potential therapeutic value of NK4 to inhibit metastasis and the subsequent growth of colon carcinoma.
To investigate effects of NK4 on invasion, metastasis, and growth of colon carcinoma in vivo, we took advantage of hydrodynamics-based gene delivery and expression. [20] [21] [22] Previous reports indicated that the hydrodynamics-based delivery of a naked plasmid enabled highly efficient expression of the gene, particularly in liver. We now report that efficient expression of NK4 by this delivery method inhibited liver metastasis and subsequent invasive growth of colon cancer cells and prolonged survival in mice was achieved.
Materials and methods

Materials
Human recombinant HGF was purified from the conditioned medium of Chinese hamster ovary (CHO) cells transfected with human HGF cDNA. 23 Recombinant human NK4 was purified from culture medium of CHO cells, which stably secrete human NK4, using three-step chromatographies (will be published elsewhere). The purity of NK4 was 96.4% as determined by SDS-PAGE and protein staining. Polyclonal antibody against rat HGF (crossreacts with murine HGF) was obtained from the Institute of Immunology (Tokyo, Japan). Anti-c-Met (pYpYpY1230/1234/1235) phosphospecific antibody was obtained from BioSource International, Inc. (Camarillo, CA).
Cell culture and invasion assay
MC-38 murine colon adenocarcinoma cells were kindly provided by Dr Steven A Rosenberg (National Cancer Institute, Bethesda, MD) and cultured in RPMI 1640 medium containing 10% fetal bovine serum (FBS). In vitro invasion of carcinoma cells was measured using Cell Culture Insert Chambers (Becton Dickinson Labware, Franklin Lakes, NJ). The cells were seeded on Matrigel invasion chamber plates at a density of 1.5 Â 10 4 cells/cm 2 and cultured in RPMI 1640 medium containing 1% FBS. HGF and/or NK4 were added to the lower chamber and cells were cultured for 36 hours. Invasive cells appearing beneath the filter membrane were stained with hematoxylin and eosin, and counted under a microscope.
Plasmid constructions and hydrodynamics-based gene delivery
Expression plasmid pCAGGS was kindly provided from Dr Junich Miyazaki (Osaka University). 24 Expression plasmid for human NK4 (pCAGGS-NK4) was constructed by inserting the human NK4 cDNA into the unique XhoI site between the cytomegalovirus immediateearly enhancer-chicken b-actin hybrids promoter and a 3 0 -flanking sequence of the rabbit b-globin gene of the pCAGGS vector. Plasmid was amplified in Escherichia coli JM109 cells, extracted by the alkaline lysis method, and purified by CsCl-ethidium bromide gradient centrifugation and kept in saline at À201C until use. For hydrodynamics-based delivery of the expression plasmid, the plasmid DNA was intravenously administered as described by Liu et al 20 Briefly, plasmid DNA solution (pCAGGS-empty or pCAGGS-NK4) in saline was injected into the tail vein at 0.08 ml/g body weight within 5 seconds.
Experimental models for liver metastasis and intrahepatic tumor inoculation
Male C57BL/6 mice (7 weeks old) (Japan SLC Inc., Hamamatsu, Japan) were used. For experimental model for liver metastasis, plasmid solution was injected into the tail vein as described above. At 1 day after administration of the plasmid, MC-38 cells (2 Â 10 5 ) were injected into the spleen and pressure was held with a sterile cotton tip applicator until the injection site was hemostatic. The spleen was subsequently removed and the subcostal incision was closed with absorbable sutures.
For intrahepatic tumor inoculation model, MC-38 cells (1 Â 10 6 ) were inoculated subcapsularly into the left liver parenchyma. After 3 days, plasmid solution was injected into the tail vein as described above and mice were analyzed 14 days after tumor inoculation.
Measurement of NK4 levels in plasma and organs
Tissues were homogenized in buffer composed of 20 mM Tris-HCl (pH 7.5), 2 M NaCl, 0.1% Tween-80, 2 mM EDTA and 1 mM PMSF, and centrifuged at 12,000 g for 30 minutes. The supernatant was used as the tissue extract. Concentrations of NK4 in tissue extracts and plasma were determined using enzyme-linked immunosorbent assay (ELISA) kit for human NK4 (Institute of Immunology, Tokyo). Recombinant human NK4 was used for the determination of the standard curve. Mouse HGF level in the hepatic tissue extract was determined using an ELISA kit for rodent HGF (Institute of Immunology, Tokyo). Human and rodent HGF ELISA kits specifically detect human HGF (also human NK4) and mouse HGF, respectively.
Histopathological analysis
For conventional histological analysis, tissues fixed in formalin were embedded in paraffin, and tissue sections were stained with hematoxylin and eosin. Apoptotic cell death was determined by in situ detection of DNA fragmentation using terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL assay). 15, 17 Paraffin-embedded tissue sections (3 mm thick) were subjected to TUNEL staining according to the protocol specified by the manufacturer (Apoptosis Detection System; Promega, Madison, WI).
For blood vessel staining, tissues were fixed in 70% ethanol and embedded in paraffin. Tissue sections were then quenched with 3% hydrogen peroxide in phosphate-buffered saline (PBS) for 5 minutes and washed in PBS. The sections were exposed for 30 minutes to 10% normal rabbit serum in PBS and incubated with antibody against von Willebrand factor (vWF) (diluted 1:100; Dako, Glostrup, Denmark) overnight at 41C. The sections were incubated with biotinylated horseradish peroxidase-conjugated rabbit anti-rat IgG antibodies (diluted 1:200; DAKO) for 30 minutes. The reaction was observed by incubating the sections with substrate solution containing diaminobenzidine and hydrogen peroxide. The number of blood vessels was counted under a light microscope at Â 100 magnification using at least 20 randomly selected fields per each section. For detection of proliferating cells, tissue sections fixed in 10% formalin solution were subjected to immunostaining for PCNA as described elsewhere. 15, 17 To analyze the expression of HGF and phosphorylation of the c-Met receptor, tissues were fixed in ethanol and formalin, respectively. The tissue sections were incubated overnight with anti-rat HGF IgG (10 mg/ml) or anti-phospho-Met (pYpYpY1230/1234/1235) (diluted 1:50) at 41C and then were incubated with the DAKO rabbit Envision plus visualization system for 30 minutes. The sections were counterstained with hematoxylin.
For measurement of areas of intrahepatic metastases, tissue sections were stained with hematoxylin and eosin. The area of each metastasis was traced and quantified in tissue sections, using a computerized morphometric analysis (NIH image, version 1.62). To semiquantitate invasiveness of the colon cancer cells in the liver, periphery of each metastasis was traced and invasive periphery was quantified, using a computerized morphometric analysis (NIH image, version 1.62). Morphometric analysis was carried out in 10 randomly selected metastases in each experimental group. We defined the invasion score based on histological observations as follows: score 0, invasion was undetectable; score 1, invasive regions were less than 30% in periphery of each metastasis; score 2, invasion regions were 30-80% in periphery of each metastasis; score 3, invasion was extensive, and the border between normal hepatic tissue and tumor regions could not be distinguished in most of periphery (more than 80%). 25 
Immunoprecipitation and Western blot
To detect phosphorylation of the c-Met receptor in cultured cells, the cells were serum-starved 24 hours, and treated with HGF and/or NK4 for 10 minutes. Cell lysates were prepared, equivalent amounts of protein were incubated overnight with a monoclonal antibody against Met (B-2; Santa Cruz Biotechnology, Santa Cruz, CA), and then incubated for 2 hours with protein G-Sepharose. The immunoprecipitates were separated by SDS-PAGE, electroblotted onto polyvinylidene difluoride membranes, and the proteins were probed with polyclonal antibody against phospho-Met (pYpYpY1230/1234/1235; BioSource International, Inc., CA). Immunoreactive bands were visualized by the enhanced chemiluminescence system (Amersham). After being ''stripped'', the membranes were reprobed with an antibody against Met (B-2; Santa Cruz Biotechnology, Santa Cruz, CA) as a loading control.
To analyze the phosphorylation of c-Met in tumor tissues, metastatic tumors in the liver were excised and homogenized in 20 mM Tris-HCl buffer (pH 7.5) containing 150 mM NaCl, 2 mM PMSF, 10 mM EDTA, 0.5% Triton X-100, 1 mM Na 3 VO 4 , and 48 mg/ml aprotinin. The homogenate was centrifuged at 15,000 rpm for 30 minutes and the resultant supernatant containing 4 mg of proteins was subjected to immunoprecipitation and Western blot, as described above.
Statistical analysis
For statistical analyses, we used unpaired Student's t-test (two-tailed) unless otherwise mentioned. Differences were considered to be statistically significant at Po.05. Survival time of mice was determined on a Kaplan-Meier survival plot followed by a log-rank (Mantel-Cox) test.
Results
Transgene expression after hydrodynamics-based plasmid delivery
Previous studies demonstrated that the hydrodynamicsbased gene transfection achieved a highly efficient expression of distinct types of genes predominantly in the liver. [20] [21] [22] To analyze the dose-dependent expression of human NK4 gene following hydrodynamics-based gene delivery, mice were injected with various amounts of pCAGGS-NK4 plasmid and the plasma NK4 level was measured using ELISA at 24 hours after gene delivery (Fig 1a) . Although the plasma NK4 was undetectable in mice given pCAGGS-empty plasmid, the plasma NK4 level dose dependently increased after delivery of the pCAGGS-NK4 plasmid, and the plasma NK4 level reached a peak value, 131.6716.0 ng/ml at 15 mg of pCAGGS-NK4 plasmid. When a time-dependent change in plasma NK4 was measured in mice injected with 5 and 15 mg of pCAGGS-NK4, the plasma NK4 level reached a maximal value at 24 hours after injection and then decreased to lower levels later than 3 days postinjection. However, the plasma NK4 level was sustained over 8.7 and 10.6 ng/ml, respectively, with 5 and 15 mg of pCAGGS-NK4 until 14 days postinjection (Fig 1b) . The plasma NK4 level decreased to 3.970.2 and 4.170.2 ng/ ml on day 21 after 5 and 15 mg of pCAGGS-NK4 injection had been given, respectively.
To determine major organs that expressed NK4, tissue NK4 levels were measured using extracts of the liver, kidney, and spleen (Fig1c). The highest tissue NK4 level was seen in the liver on day 1 postinjection: 8.8 and 16.1 mg/g tissue after 5 and 15 mg pCAGGS-NK4 injection, respectively. The hepatic NK4 level thereafter decreased gradually until day 21, whereas the hepatic NK4 level, respectively, remained at 2.7 and 3.9 mg/g tissue on day 21 after 5 and 15 mg of pCAGGS-NK4 injection. The increase in tissue NK4 level was also seen in NK4 suppresses liver metastasis of colon cancer J Wen et al the kidney (0.6 mg/g tissue) and spleen (0.8 mg/g tissue) on day 1 postinjection after 5 mg of pCAGGS-NK4 injection, whereas NK4 levels in these tissues were much lower than that noted in the liver (Fig 1c) . Likewise, NK4 levels in the lung and heart were lower than levels in the kidney and spleen (not shown). These results indicate that the liver is the predominant organ that expresses NK4 following hydrodynamics-based delivery of the NK4 gene.
Inhibition of invasion of MC-38 cells by NK4
To determine if HGF affects invasion of MC-38 colon cancers, we analyzed the in vitro invasion of MC-38 cells using a Matrigel invasion chamber. MC-38 cells were cultured for 36 hours in the absence or presence of HGF and/or NK4, and the number of invasive cells that NK4 suppresses liver metastasis of colon cancer J Wen et al migrated beneath the filter membrane was determined (Fig 2) . In control culture, the number of invasive cells remained 13.873.7 per microscopic field. The addition of HGF dose dependently increased the invasion of cancer cells and the maximal stimulation by five-fold was seen at 10 ng/ml (110 pM) HGF. When NK4 was added in the presence of 110 pM HGF, NK4 dose dependently inhibited the invasion of cancer cells and this invasion was inhibited to the basal level by 110 nM NK4. The addition of NK4 alone had no significant effect on the invasion of cancer cells. These results indicate that HGF potently enhances the invasion of MC-38 colon cancer cells and that NK4 inhibits the invasion of the cells stimulated by HGF. On the other hand, when effects of HGF or NK4 on proliferation and apoptosis of MC-38 cells were examined, HGF and NK4 had no direct effect on proliferation and apoptosis of the cells (not shown).
As tyrosine phosphorylation of the c-Met is a critical event in the activation of intracellular signal transduction, we analyzed tyrosine phosphorylation of c-Met receptor using Western blots (Fig 2c) . In quiescent MC-38 cells, tyrosine phosphorylation was marginal, whereas a treatment of cells with HGF for 10 minutes induced tyrosine phosphorylation of c-Met receptor. When NK4 was simultaneously added with HGF to the cells, NK4 dose dependently inhibited tyrosine phosphorylation of c-Met receptor. The addition of NK4 alone had no effect on tyrosine phosphorylation of c-Met receptor. Taken together, these results indicated that NK4 competitively inhibits HGF-induced tyrosine phosphorylation of c-Met receptor, thereby leading to the inhibition of cancer cell invasion induced by HGF.
Inhibition of liver metastasis by NK4 gene expression
To determine if hydrodynamics-based delivery and expression of NK4 would inhibit liver metastasis of colon cancer cells, MC-38 colon cancer cells were injected into the spleen 1 day after respective administration of pCAGGS-empty and pCAGGS-NK4 plasmids, and subsequent metastasis to the liver was determined (Fig  3) . At 21 days after inoculation of the cells, MC-38 cells metastasized to the liver and formed visible metastatic nodules (Fig 3a) . The number of surface metastatic nodules larger than 1 mm in diameter reached 23.372.9 in mice given 5 mg empty plasmid (Fig 3b) . The number of metastatic nodules in the liver was not significantly changed when mice were given saline alone (not shown). On the other hand, pCAGGS-NK4 treatment inhibited metastasis to 26.6% of the control value (6.271.8; Po.001). The liver weight in control mice administered empty plasmid reached 1.770.1 g, whereas it remained 1.370.1 g (Po.01) in mice given NK4 plasmid, suggesting that formation of numerous metastatic nodules in control mice led to an increase in liver weight. Likewise, on day 21 postinoculation, accumulation of cancerous ascites reached 6507160 ml in control mice given an empty plasmid, whereas accumulation of cancerous ascites in pCAGGS-NK4-treated mice was 19.8% of the control value (129768 ml; Po.01) (Fig 3c) .
There are potentially distinct explanations for the inhibitory effect of NK4 on the formation of metastatic nodules in the liver: (1) NK4 might inhibit the invasion of cancer cells from blood vessels into hepatic tissues, thereby decreasing the incidence of hepatic colonization of cancer cells; (2) NK4 might inhibit subsequent growth of metastatic colonies in the liver, thereby inhibiting the number of visible metastatic nodules; (3) NK4 might inhibit both processes, that is, hepatic colonization and subsequent growth of colonized cancer cells. We therefore analyzed histological characteristics of hepatic metastases of colon cancer cells. In control mice given an empty plasmid, large and small metastatic nodules were histologically visible and each nodule had an irregular shape (Fig 4a) . In contrast, in mice given the NK4 plasmid intrahepatic metastatic nodules were relatively smaller than in control mice and had a round shape (Fig 4a) . The number of microscopically visible intrahepatic metastatic nodule was inhibited by NK4 gene expression to 33.6% of a value in control mice given an empty plasmid (Fig 4b) . When metastatic nodules were 2 , respectively, in mice given an empty plasmid (Fig 4c) . On the other hand, in mice given the NK4 plasmid, the numbers of nodules 41.0 mm 2 , 0.1-1.0 mm 2 , and o0.1 mm 2 were 1.170.5, 2.971.3, and 13.270.5 per 100 mm 2 , respectively. Thus, metastatic nodules less than 0.1 mm 2 was not significantly changed by NK4 gene expression, whereas the number of metastatic nodules larger than 0.1 mm 2 was much higher in control mice than that in mice given the NK4 plasmid. Likewise, the mean area of each metastatic nodule was 3.270.8 mm 2 in control mice, while it remained at 0.570.3 mm 2 in mice given the NK4 plasmid (Fig 4d) . These results suggest that hepatic expression of NK4 inhibits both hepatic colonization of cancer cells and the subsequent growth of metastatic cancer cells in the liver.
Inhibition of tumor angiogenesis by NK4 gene expression
As HGF has no direct mitogenic and antiapoptotic effects on MC-38 colon cancer cells, we assumed that the suppression of intrahepatic tumor growth by NK4 gene expression might be associated with angiogenesis in tumor tissues. To address this issue, blood vessels in tumor tissues was analyzed by immunostaining for vWF. In control mice given the empty plasmid, the blood vessel density in tumor tissue reached 8.070.7 vessels per microscopic field (Fig 5) . However, blood vessel density in mice treated with NK4 plasmid was decreased to 3.571.6 vessels per microscopic field, the value being 43.8% of the control value (Po.01). Furthermore, measurement of the number of proliferating and apoptotic cells in tumor tissues, as respectively determined by PCNA staining and by TUNEL assay, revealed that NK4 gene expression did not affect the number of PCNA-positive tumor cells (51.5% in control mice versus 48.9% in NK4 plasmid-treated mice; P ¼ .1903) but did increase the number of apoptotic tumor cells (1.4% in control mice versus 2.8% in NK4 plasmid-treated mice; Po.01). Together with the lack of mitogenic and antiapoptotic activities of HGF on MC-38 cells, these results strongly suggest that NK4 gene expression suppresses tumor growth mainly by inhibiting tumor angiogenesis.
Inhibition of intrahepatic invasion and c-Met receptor activation
When histological appearance of metastases in the liver was analyzed, colon cancer cells in peripheral regions of metastases spread and invaded hepatic tissue; thus, the border between tumor lesions and surrounding hepatic tissue was not obvious in control mice given an empty plasmid (Fig 6a) . In contrast, in mice given the NK4 plasmid, the local invasion of cancer cells was inhibited and the tumor lesions were separated from normal hepatic tissue (Fig 6a) . Histological scoring of cancer cell invasion in control mice reached 2.670.3, whereas the invasion score was significantly inhibited to 0.670.4 by the expression of NK4 (Fig 6b) .
As HGF potently enhances the invasion of MC-38 colon cancer cells and NK4 inhibits HGF-induced the invasion of cancer cells, NK4 may inhibit c-Met receptor activation, thereby inhibiting cancer cell invasion in the liver. We therefore analyzed the predominant source of HGF that might affect invasive behavior of cancer cells by immunostaining for HGF in hepatic sections (Fig 7) .
Immunoreactive HGF was undetectable in metastasized colon cancer cells and the lack of HGF expression in colon cancer cells was consistent with the finding that MC-38 colon cancer cells did not produce HGF (not shown). On the other hand, positive signals for HGF were predominantly localized in sinusoidal regions. Since nonparenchymal liver cells such as sinusoidal endothelial cells and hepatic macrophages express HGF, 26 HGF derived from these sinusoidal nonparenchymal cells is likely to be the predominant source of HGF affecting invasive behavior of cancer cells. In addition, the hepatic HGF level was determined by ELISA to be 80720 ng/g tissue (7.871.9 Â 10 À13 mol/g tissue). As the mean hepatic NK4 level ranged from 2.7 mg/g tissue (3.9 Â 10 À11 mol/g tissue) to 8.8 mg/g tissue (1.3 Â 10 À10 mol/g tissue) during the 21 days after administration of the NK4 plasmid (Fig  1c) , hepatic concentration of NK4 was 50-167 times higher than that of HGF, suggesting that NK4 expressed in the liver could significantly inhibit biological actions of endogenous HGF.
To obtain further evidence that NK4 might inhibit c-Met receptor-mediated signal transduction, activation status of the c-Met receptor was analyzed immunohistochemically and by Western blots using an anti-phosphorylated c-Met antibody. In control mice, tyrosine-phosphorylated Met was detectable in cancer cells, hence the c-Met receptor was activated in these cancer cells in hepatic metastases (Fig 7A) . However, in mice given the NK4 plasmid, tyrosinephosphorylated Met was mostly undetectable in cancer NK4 suppresses liver metastasis of colon cancer J Wen et al cells. Likewise, when the phosphorylation status of c-Met in excised cancer tissue was analyzed using Western blots, gene expression of NK4 strongly suppressed tyrosine phosphorylation of the c-Met receptor (Fig 7B) . Taken together, these results strongly suggest that NK4 expressed in the liver inhibited the activation of c-Met receptor in cancer cells, thereby inhibiting the local invasion of colon cancer cells as an HGF antagonist.
Inhibition of invasive growth in an intrahepatic tumorbearing mouse
We next addressed if expression of NK4 would also inhibit invasive growth in tumor-bearing mice, when expression plasmid was administered postinoculation of tumor cells. MC-38 cells (1 Â 10 6 ) were directly injected into the left liver parenchyma and the plasmid DNA was administered 3 days after tumor inoculation (Fig 8) . At 2 NK4 suppresses liver metastasis of colon cancer J Wen et al weeks after tumor inoculation, volume of tumors reached 6.371.7 cm 3 in control mice given empty plasmid, whereas it was suppressed to 2.971.1 cm 3 (Po.05) in mice given 5 mg pCAGGS-NK4 (Fig 8a-c) . In control mice, cancer cells spread and invaded hepatic tissue, whereas the local invasion of cancer cells was inhibited by the expression of NK4 (Fig 8d and e) . Histological scoring of cancer cell invasion in control mice reached 2.370.3, whereas the invasion score was significantly inhibited to 0.670.4 by the expression of NK4 (Fig 8f) .
When blood vessels in tumor tissues were analyzed by immunostaining for vWF, the blood vessel density in tumor tissue in mice given NK4 plasmid was decreased to 44.8% of the control value in mice given empty plasmid (Fig 8g-i) . On the other hand, the number of TUNEL-positive apoptotic cells increased to 2.7-fold higher level in mice given NK4 plasmid, compared to the control level in mice given empty plasmid (Fig 8j-l) . These results indicate that NK4 gene expression suppresses invasive tumor growth, even when NK4 plasmid was administered in tumor-bearing mice. (Fig 9) . The mice were given an empty plasmid or NK4 plasmid and then MC-38 cells (5 Â 10 5 cells) were injected into the spleen 1 day after the plasmid administration. Control mice (n ¼ 11) given an empty plasmid died of metastatic cancer within 25 days after inoculation of the cancer cells. In mice given 5 mg NK4 plasmid (n ¼ 10), the mice died of cancer from day 22 postinoculation and all mice died within 31 days. In mice given 15 mg NK4 plasmid (n ¼ 10), the mice died of cancer from day 27 and all died within 38 days. The mean survival times for mice given empty plasmid, 5 mg NK4 plasmid, and 15 mg NK4 plasmid were 23.1, 27.6, and 32.0 days respectively. Thus, the expression of NK4 resulted in significant improvement in the survival of mice bearing hepatic metastases of colon cancer cells.
Discussion
Tumor cells metastasize through a series of processes: (1) dissociation of tumor cells from primary tumors; (2) invasion through the basement membrane and surrounding tissues; (3) invasion into blood and lymph vessels and locomotion to distant tissues; and (4) invasion from blood and lymph vessels into tissues and formation of metastatic colonies. Liver metastasis by intrasplenic injection of colon cancer cells used in this study seems to involve the latter processes; locomotion to distant tissues, invasion from blood vessels (extravasation) into hepatic tissue, and formation of metastatic colonization and subsequent growth. The inhibition of liver metastasis by hydrodynamics-based gene expression of NK4 indicates that NK4 might inhibit these distinct processes leading to metastatic colony formation and growth in the liver. As (1) NK4 inhibited in vitro invasion of MC-38 colon cancer cells, (2) NK4 gene expression inhibited invasive behavior of cells in the liver, and (3) NK4 gene expression suppressed tumor growth primarily due to angiogenesis inhibition, NK4 gene expression may inhibit both invasion and colonization of colon cancer cells, and the subsequent growth of colonies in the liver.
NK4 inhibits angiogenic responses induced by basic fibroblast growth factor and vascular endothelial cell growth factor, as well as by HGF. 17 In addition, angioinhibitory actions of NK4 do not depend on its c-Met receptor binding ability. 27 We found that hepatic gene expression of NK4 decreased blood vessel density in colon cancer tissues in the liver in association with increase in apoptotic cancer cells, yet without change in the number of mitotic cancer cells. Moreover, HGF and NK4 had no direct effect on proliferation, apoptosis, and expression of Bcl-family proteins in MC-38 cells (not shown). Although mechanisms by which NK4 inhibits angiogenesis remain to be further addressed, these results strongly suggest that inhibitory effects of NK4 on growth of MC-38 colon cancer cells can primarily be attributed to the inhibition of angiogenesis by NK4.
Intratumoral or intraperitoneal administration of replication-incompetent recombinant adenovirus for NK4 gene expression inhibited metastasis and growth of distinct types of cancer cells, thereby increasing the potential use of the NK4 gene for antimetastasis and antiangiogenesis therapy of cancers. [28] [29] [30] On the other hand, while the hydrodynamics-based gene delivery method of a naked plasmid may be arguable or should be modified for gene therapy, it has advantages in terms of efficient gene transduction and large-scale preparation, without possible immunologic responses. Moreover, hydrodynamics-based gene delivery enabled high level and predominant transgene expression in the liver. The predominant expression in the liver may be related to its architecture, the liver is highly vascularized and hepatocytes are highly susceptible to plasma components. As the liver is overwhelmingly the most common site of colon cancer metastases and intrahepatic growth, hydrodynamics-based transduction of the NK4 gene is one potential approach for the treatment of patients with colon cancer.
Based on the thesis that tumor growth depends on tumor angiogenesis, antiangiogenesis strategy has achieved successful results in experimental systems, and antiangiogenic molecules are currently in clinical trials. 31 However, experimental evidence and clinical studies suggest that hypoxia directly increases the invasive and metastatic potential of tumor cells [32] [33] [34] and correlates with an increased risk to develop distant metastases. [35] [36] [37] Therefore, it has become clear that antiangiogenic strategies have a drawback of inducing tumor hypoxia, Figure 9 Prolonged survival of tumor-bearing mice treated with NK4 gene delivery. Mice received 5 or 15 mg/mouse pCAGGS-empty or pCAGGS-NK4 plasmid by hydrodynamics-based procedure 1 day before the intrasplenic inoculation with 5 Â 10 5 MC-38 cells. Each experimental group consisted of at least 10 mice. A statistically significant difference was evident in the log-rank analysis of a Kaplan-Meier survival curve. Po.001 for empty plasmid versus 5 mg NK4 plasmid; Po.0001 for empty plasmid versus 15 mg NK4 plasmid.
NK4 suppresses liver metastasis of colon cancer J Wen et al thereby increasing the invasive and metastatic potential of tumor cells. 38 Although mechanisms by which hypoxia increases the invasive and metastatic potential of tumor cells are largely unknown, Pennacchietti et al 39 reported that hypoxia activates transcription of the c-met gene, thereby amplifying invasive signaling mediated by HGF and c-Met. The results suggest that more effective tumor treatment could be achieved by combining an antiangiogenic strategy and an inhibitor for HGF-c-Met signaling. Taken together, bifunctional characteristics of NK4 as an HGF-antagonist and an angiogenesis inhibitor reinforces the potential therapeutic value of NK4, in terms of the inhibition of c-Met receptormediated invasion and metastasis, in addition to the inhibition of angiogenesis-dependent-tumor growth. NK4 gene transduction in anti-invasion-metastasis and antiangiogenesis therapy of colon carcinoma can be given due consideration.
